New Windsor, New York — According to state and local development sources, Garonit Pharmaceutical plans to invest $46,100,000.00 to build out 200,000 square feet of new space in New Windsor. The company plans to occupy the new space in New Windsor, on or about January 1, 2027. According to the company website Garonit Pharmaceutical, a US based multi national company is owned by Rohit and Nitin Garg with its headquarters in New Jersey. We take pride in our operations and quality. We remain focused on a world wide platform while maintaining our local feel to the customers. Garonit Pharmaceuticals has successfully served both Fortune 500 companies and small-scale industries across North America, LATAM, and EMEA. Our manufacturing plants in New Jersey, USA, are fully compliant with cGMP and US-FDA regulations. Additionally, we maintain warehouses in Germany and the UK. As one of the few companies in North America, Garonit Pharmaceuticals holds the prestigious CEP from EDQM for CHG20%. Our CHG20% product adheres to the monographs of USP, BP, EP, JP, and IP. In addition to our commercial endeavors, Garonit Pharmaceuticals collaborates with renowned philanthropic organizations such as UNICEF, WHO, and The Red Cross, aiming to create a better world. Through our own trust, the Neelam Garg Foundation, we actively support girls’ education initiatives for underprivileged communities.

To learn more about Garonit Pharmaceutical, visit https://garonitpharma.com/

Company Contact:
Rohit Garg, Owner
973-227-1700

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.